Prosensa's P2P Acquisition

Prosensa raised a round of funding on November 24, 2014. Investors include BioMarin Pharmaceutical.

Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, w…

Articles about Prosensa's P2P Acquisition: